Zydus Cadila gets USFDA nod to market generic Deferasirox tablets

The company has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Deferasirox tablets in the strengths of 90 mg, 180 mg, and 360 mg, Zydus Cadila said in a statement.

Original source: https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-to-market-generic-deferasirox-tablets/66706358?utm_source=RSS&utm_medium=ETRSS

Related Posts